VOLUNTARY ANNOUNCEMENT-ACKNOWLEDGEMENT OF CTN BY THE TGA FOR PHASE I CLINICAL TRIAL OF ATG-101 IN SOLID TUMORS AND NON-HODGKIN LYMPHOMAS

Sep 02, 2021View PDF